134 related articles for article (PubMed ID: 2890188)
1. Psychotropic drug use with successful and unsuccessful community placed developmentally disabled groups.
Harder SR; Kalachnik JE; Jensen MA; Feltz J
Res Dev Disabil; 1987; 8(2):191-202. PubMed ID: 2890188
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements.
Martin JE; Agran M
Appl Res Ment Retard; 1985; 6(1):33-49. PubMed ID: 2859836
[TBL] [Abstract][Full Text] [Related]
3. Movement of developmentally disabled individuals among out-of-home residential facilities.
Heal LW; Bruininks RH; Lakin KC; Hill BK; Hauber FA
Res Dev Disabil; 1989; 10(3):295-313. PubMed ID: 2772289
[TBL] [Abstract][Full Text] [Related]
4. Trends in the residential (inpatient) treatment of individuals with a dual diagnosis.
Spreat S; Behar D
J Consult Clin Psychol; 1994 Feb; 62(1):43-8. PubMed ID: 7913478
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
Clarke DJ; Kelley S; Thinn K; Corbett JA
J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
[TBL] [Abstract][Full Text] [Related]
7. Knowledge and expectations of direct support professionals towards effects of psychotropic drug use in people with intellectual disabilities.
de Kuijper G; van der Putten AAJ
J Appl Res Intellect Disabil; 2017 Dec; 30 Suppl 1():1-9. PubMed ID: 28467003
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community.
Thinn K; Clarke DJ; Corbett JA
J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():397-407. PubMed ID: 1979993
[TBL] [Abstract][Full Text] [Related]
9. Brief report: reliability and validity of instruments for assessing psychotropic medication effects on self-injurious behavior in mental retardation.
Schroeder SR; Rojahn J; Reese RM
J Autism Dev Disord; 1997 Feb; 27(1):89-102. PubMed ID: 9018584
[No Abstract] [Full Text] [Related]
10. A survey of psychotropic medication in mental retardation facilities.
Tu JB
J Clin Psychiatry; 1979 Mar; 40(3):125-8. PubMed ID: 33967
[TBL] [Abstract][Full Text] [Related]
11. Reducing psychotropic drug use in an institution for the retarded.
LaMendola W; Zabaria ES; Carver M
Hosp Community Psychiatry; 1980 Apr; 31(4):271-2. PubMed ID: 7390422
[No Abstract] [Full Text] [Related]
12. Overview of pharmacotherapy: current status and future directions.
Aman MG
J Ment Defic Res; 1987 Jun; 31 ( Pt 2)():121-30. PubMed ID: 2887660
[No Abstract] [Full Text] [Related]
13. Psychotropic drug use among people with intellectual disability before and after deinstitutionalization.
Nøttestad JA; Linaker OM
J Intellect Disabil Res; 2003 Sep; 47(Pt 6):464-71. PubMed ID: 12919197
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
[TBL] [Abstract][Full Text] [Related]
15. Reducing the use of restrictive procedures in a residential facility.
Davidson NA; Hemingway MJ; Wysocki T
Hosp Community Psychiatry; 1984 Feb; 35(2):164-7. PubMed ID: 6698503
[TBL] [Abstract][Full Text] [Related]
16. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.
Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207
[TBL] [Abstract][Full Text] [Related]
17. High cost residential placements for adults with intellectual disabilities.
McGill P; Poynter J
J Appl Res Intellect Disabil; 2012 Nov; 25(6):584-7. PubMed ID: 23055291
[TBL] [Abstract][Full Text] [Related]
18. Problem behavior and psychiatric impairment within a developmentally disabled population. III: Psychotropic medication.
Jacobson JW
Res Dev Disabil; 1988; 9(1):23-38. PubMed ID: 3353539
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
Janowsky DS; Barnhill LJ; Davis JM
J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
[TBL] [Abstract][Full Text] [Related]
20. Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors.
García-Domínguez L; Navas P; Verdugo MÁ; Arias VB; Gómez LE
J Appl Res Intellect Disabil; 2022 Sep; 35(5):1109-1118. PubMed ID: 35384179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
